Does Rallies show 13F holders for SHC?

Yes. Rallies tracks hedge fund and 13F ownership data for SHC, including fund names, share counts, latest tracked quarter, and position changes when available.

Is SHC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SHC. It does not provide personalized investment advice.

SHC (Sotera Health Company Common Stock) Stock Analysis - Hedge Fund Holdings

Sotera Health Company Common Stock (SHC) is a publicly traded Healthcare sector company. As of May 20, 2026, SHC trades at $15.54 with a market cap of $4.38B and a P/E ratio of 37.65. SHC moved +2.04% today. Year to date, SHC is -15.03%; over the trailing twelve months it is +21.29%. Its 52-week range spans $9.53 to $19.85. Analyst consensus is strong buy with an average price target of $22.17. Rallies surfaces SHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns SHC stock?

Hedge funds tracked by Rallies that own SHC include Sculptor Capital, Maverick Capital, DME Capital, Bridgewater Associates, and Centerbook Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Sotera Health Company Common Stock.

SHC Key Metrics

Key financial metrics for SHC
Metric	Value
Price	$15.54
Market Cap	$4.38B
P/E Ratio	37.65
EPS	$0.41
Dividend Yield	0.00%
52-Week High	$19.85
52-Week Low	$9.53
Volume	2.12M
Avg Volume	0
Revenue (TTM)	$1.19B
Net Income	$117.80M
Gross Margin	55.26%

Top Hedge Funds Holding SHC

Sculptor Capital holds 21.72M shares of SHC, changed +3.42% as of Mar 31, 2026.
Maverick Capital holds 3.50M shares of SHC, changed +3.50% as of Sep 30, 2024.
DME Capital holds 2.07M shares of SHC, changed +347.82% as of Mar 31, 2026.
Bridgewater Associates holds 695.39K shares of SHC, changed +0.00% as of Mar 31, 2026.
Centerbook Partners holds 146.85K shares of SHC, changed -3.08% as of Mar 31, 2026.

Latest SHC News

Sotera Health Affiliates Offer 31.8 Million Shares, Company Receives No Proceeds — May 11, 2026
Sotera Health Sees 10% Q1 Revenue Growth, Names Alton Shader CEO — May 5, 2026
Sotera Health Q1 Revenue Forecast at $270M, EPS Seen $0.09 — May 4, 2026
Sotera Health Affiliates to Sell 25 Million Shares in Secondary Offering — Mar 4, 2026
Sotera Health Q4 Revenue Rises 4.6% to $303.4M, EPS Tops Forecast — Feb 24, 2026

Recent SHC Insider Trades

WARBURG PINCUS & CO. sold 19.10M (~$289.75M) on May 13, 2026.
WARBURG PINCUS & CO. sold 19.10M (~$289.75M) on May 13, 2026.
GTCR INVESTMENT XI LLC sold 12.74M (~$193.17M) on May 13, 2026.

SHC Analyst Consensus

6 analysts cover SHC: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $22.17.

Common questions about SHC

Who owns SHC stock?: Hedge funds tracked by Rallies that own SHC include Sculptor Capital, Maverick Capital, DME Capital, Bridgewater Associates, and Centerbook Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Sotera Health Company Common Stock.
Does Rallies show 13F holders for SHC?: Yes. Rallies tracks hedge fund and 13F ownership data for SHC, including fund names, share counts, latest tracked quarter, and position changes when available.
Is SHC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SHC. It does not provide personalized investment advice.